SecBot SecBot
144 ·Filed Nov 5, 2026

VCEL

Vericel Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 12h ago SEC0001959173-26-007788
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small and routine. Monitor for any subsequent Form 4 filings to confirm execution and for any pattern of larger insider sales.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$51.78
T+0 close · Nov 5, 2026 · via day close
Latest settled
+10.89%
T+5 · $57.42
Vs SPY
+7.60%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $51.78entry
  2. T+1 · 11d ago +5.48%α +5.17% · $54.62
  3. T+5 · 5d ago +10.89%α +7.60% · $57.42
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jonathan Siegal, an officer of Vericel Corp, filed a Form 144 notice of intent to sell 1,500 shares of common stock, valued at approximately $79,350. The shares were acquired via stock option exercise on the same day. The sale is small relative to the company's $2.1B market cap and represents a routine insider transaction.

Key Facts

  • Jonathan Siegal, an officer, filed Form 144 to sell 1,500 shares of common stock.
  • Estimated value of the proposed sale is $79,350.
  • Shares were acquired via stock option exercise on November 5, 2026.
  • The sale is intended to be executed on the same day as the filing (November 5, 2026).
  • The filing represents intent to sell; the actual sale may not occur.

Financial Impact

Proposed sale of 1,500 shares valued at $79,350, representing less than 0.004% of the company's $2.1B market cap.

dilution

Risk Factors

  • Insider sale is small and likely pre-planned; no material risk to shareholders.
  • Form 144 is an intent to sell; the sale may not be executed.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007788
Document: 0001959173-26-007788-index.html0001959173-26-007788
Document: 0001959173-26-007788.txt0001959173-26-007788

Track record

30 reports on VCEL

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +31.08% at T+60 after the May 7, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
  2. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 1/10 Entry $57.42 Now $57.48 +0.10% settles Feb 10
  4. Nov 10, 20266d ago 144 Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  5. Nov 9, 20267d ago 144 Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  6. Nov 9, 20267d ago 144 Neutral 3/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  7. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  8. Nov 6, 202610d ago 144 Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $54.62 Now $57.48 +5.24% settles Feb 4
Showing 10 of 30

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026